Your browser doesn't support javascript.
loading
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer.
Flörkemeier, Inken; Hillmann, Julia S; Weimer, Jörg P; Hildebrandt, Jonas; Hedemann, Nina; Rogmans, Christoph; Dempfle, Astrid; Arnold, Norbert; Clement, Bernd; Bauerschlag, Dirk O.
Afiliación
  • Flörkemeier I; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Hillmann JS; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, 24118 Kiel, Germany.
  • Weimer JP; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Hildebrandt J; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Hedemann N; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, 24118 Kiel, Germany.
  • Rogmans C; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Dempfle A; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Arnold N; Institute of Medical Informatics and Statistics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Clement B; Department of Gynaecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
  • Bauerschlag DO; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, 24118 Kiel, Germany.
Int J Mol Sci ; 23(18)2022 Sep 10.
Article en En | MEDLINE | ID: mdl-36142413

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Alemania